Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Pharma Consultancy in Indore in 2026 for USFDA and Schedule M Compliance

What does it take to satisfy two regulatory frameworks with one quality system? Explore how pharma consultancy in Indore helps Pithampur manufacturers address USFDA scrutiny, revised Schedule M, validation gaps, and data integrity risks before inspections begin.
  • Blog, Quality Management System
Pharmaceutical scientist working in a QC laboratory beside a cleanroom production line, with USFDA and Indian compliance shields illustrating data integrity and regulatory inspection readiness.

FDA IVD Guidance in 2026: What FDA Expects From 510(k) to QMSR Inspections

Since QMSR took effect in February 2026, FDA inspectors can review internal audits and management reviews. Learn what FDA IVD guidance expects, from 510(k) pathways and analytical validation to labeling, LDT status and the Form 483 gaps investigators cite most.
  • Blog, Medical Devices
FDA IVD regulation lifecycle showing in vitro diagnostic devices, analytical validation, clinical performance testing, 510(k) submission, and QMSR inspection.

Caplin Steriles Gets 10 FDA Observations; Its Response Now Takes Center Stage

The U.S. Food and Drug Administration completed an unannounced inspection of Caplin Steriles’ injectable and ophthalmic manufacturing facility in Gummidipoondi, Tamil Nadu, on August 21, 2026. The inspection ended with a Form 483 containing 10 observations. Caplin Point Laboratories said
  • News
Caplin Steriles Gets 10 FDA Observations; Its Response Now Takes Center Stage

NATCO Calls 4 FDA Observations Procedural; Response Quality Now Matters Most

NATCO Pharma’s finished dosage formulations facility in Parawada, Visakhapatnam, received a U.S. FDA Form 483 with four observations after an inspection conducted from August 17 to 21, 2026. NATCO described the observations as procedural and said it expects to address
  • News
NATCO Calls 4 FDA Observations Procedural; Response Quality Now Matters Most